PPAR γ mediates the anti-pulmonary fibrosis effect of icaritin
CONCLUSIONS: Icaritin has therapeutic potential against pulmonary fibrosis via the inhibition of myofibroblast differentiation, which may be mediated by PPARγ.PMID:34153405 | DOI:10.1016/j.toxlet.2021.06.014
Source: Toxicology Letters - Category: Toxicology Authors: Qingzhong Hua Xiaoting Huang Weixi Xie Feiyan Zhao Haipeng Cheng Ziqiang Luo Jianzhong Han Zun Wang Qian Zeng Miao Lin Tingting Zhou Jialu Zhang Can Gu Wei Liu Siyuan Tang Source Type: research